… (AL), together with that in bone marrow, PB, and TL, for the … Estimates of disease-free
survival and overall survival were … lymphoblastic leukemia and acute myeloid leukemia; chronic …

… impact of mixed donor chimerism on transplant outcomes. … that evaluated chimerism as a
predictor of relapse in AML, 33 … allogeneic transplantation for chronic myelogenous leukemia. …

… survival (OS) and relapse-free survival, whereas mixed CD33 + … /host chimerism at various
timepoints post-HCT were available. … A time-dependent indicator variable was used to define …

… with relapse (HR = .97, P = .002), relapse-free survival (HR = … post-transplant, which could
explain why early chimerism … a higher risk for relapse independent of any other indicators. This …

… populations as well as unfractionated bone marrow samples. Density gradient centrifugation
… last known follow-up; disease-free survival (DFS), from day 0 to the first indicator of relapse (…

… period had been limited to chronic myeloid leukemia (CML), with … by donor lymphocyte
infusion for many years. In AML, … hematopoietic chimerism after bone marrow transplantation …

… donors in patients with chronic myeloid leukemia (CML) 30 … data on the indication for
transplantation, donor type and stem cell … complete chimerism and sustained remissions in …

… on disease recurrence in patients with acute myeloid leukemia (AML) … rate of disease
recurrence, progression free survival was … We found that CD3 chimerism form the haplo-donor was …

… However, even in chronic myelogenous leukemia, results … Full donor chimerism was defined
by the absence of any … from acute myeloid leukemia (AML, 78%) or acute lymphoblastic …

… donor marrow transplant for treatment of chronic myeloid … in first remission of acute myeloid
leukemia: A report from the … evaluation of chimerism after bone marrow transplantation. Blood …